These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 15956785

  • 81. Biogenic amine metabolism in Biomphalaria glabrata-II. Monoamine oxidase activity.
    Mermel L, Guchhait RB, Bourgeois JG, Bueding E.
    Comp Biochem Physiol C Comp Pharmacol; 1981; 69(2):227-34. PubMed ID: 6116567
    [No Abstract] [Full Text] [Related]

  • 82. Evidence for substrate-dependent inhibition profiles for human liver aldehyde oxidase.
    Barr JT, Jones JP.
    Drug Metab Dispos; 2013 Jan; 41(1):24-9. PubMed ID: 22996261
    [Abstract] [Full Text] [Related]

  • 83. Drugs that inhibit oxidation reactions catalyzed by aldehyde oxidase do not inhibit the reductive metabolism of ziprasidone to its major metabolite, S-methyldihydroziprasidone: an in vitro study.
    Obach RS, Walsky RL.
    J Clin Psychopharmacol; 2005 Dec; 25(6):605-8. PubMed ID: 16282848
    [Abstract] [Full Text] [Related]

  • 84.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 85.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 86.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 87. Revisiting Aldehyde Oxidase Mediated Metabolism in Drug-like Molecules: An Improved Computational Model.
    Zhao J, Cui R, Wang L, Chen Y, Fu Z, Ding X, Cui C, Yang T, Li X, Xu Y, Chen K, Luo X, Jiang H, Zheng M.
    J Med Chem; 2020 Jun 25; 63(12):6523-6537. PubMed ID: 32191458
    [Abstract] [Full Text] [Related]

  • 88.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 89. Inhibition of aldehyde reductase by acidic metabolites of the biogenic amines.
    Turner AJ, Hick PE.
    Biochem Pharmacol; 1975 Sep 15; 24(18):1731-3. PubMed ID: 16
    [No Abstract] [Full Text] [Related]

  • 90. A comprehensive review of in silico approaches for the prediction and modulation of aldehyde oxidase-mediated drug metabolism: The current features, challenges and future perspectives.
    Soltani S, Hallaj-Nezhadi S, Rashidi MR.
    Eur J Med Chem; 2021 Oct 15; 222():113559. PubMed ID: 34119831
    [Abstract] [Full Text] [Related]

  • 91.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 92.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 93.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 94.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 95.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 96.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 97.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 98.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 99.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 100. Characteristics of enzymes forming 3-methoxy-4-hydroxyphenylethyleneglycol (MOPEG) in brain.
    Anderson RA, Meyerson LR, Tabakoff B.
    Neurochem Res; 1976 Oct 15; 1(5):525-40. PubMed ID: 24271656
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.